Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Hinge Bio
AddedFeb 16, 2024
UpdatedJun 18, 2026
Hinge Bio

Hinge Bio

Angel

Hinge Bio, Inc.: A private biotech firm innovating in infectious disease and oncology via its GEM-DIMER™ platform.

HQ
Burlingame, CA, US
Founded
2015
Overview
Compare
Fundraising
Employees
News
Website

Hinge Bio, Inc. is a privately-held biotechnology company founded with the mission to revolutionize therapeutics in infectious disease and oncology. Utilizing its proprietary GEM-DIMER™ platform, Hinge Bio aims to overcome the challenges of inadequate efficacy and resistance in current treatments. The company focuses on developing advanced antibody-based therapies that offer cooperative binding to disease targets, thereby enhancing therapeutic outcomes.

Hinge Bio's leadership includes a distinguished management team and a scientific advisory board composed of experts in biotechnology and medicine. The company has attracted notable investors who support its innovative approach. Key achievements include the successful development of its GEM-DIMER™ platform and progress in preclinical studies, positioning Hinge Bio as a promising player in the biotech industry. The overall impact of Hinge Bio lies in its potential to significantly improve treatment options for patients facing serious health conditions.

Hinge Bio - Similar Companies

HI-Bio logo

HI-Bio

hibio.com

Dren Bio logo

Dren Bio

drenbio.com

Peak Bio logo

Peak Bio

peak-bio.com

BioLoomics logo

BioLoomics

bioloomics.com

Global Bio logo

Global Bio

RenBio logo

RenBio

renbio.com

Igenica logo

Igenica

Hapten Sciences logo

Hapten Sciences

haptensciences.com

Meditope Biosciences logo

Meditope Biosciences

meditope.com

Biotheryx logo

Biotheryx

biotheryx.com

Haima Therapeutics logo

Haima Therapeutics

Vibe Bio logo

Vibe Bio

vibebio.com

BioHybrid Solutions logo

BioHybrid Solutions

BioHealthonomics logo

BioHealthonomics

EpiBiologics logo

EpiBiologics

epibiologics.com

Hinge Bio - Quick Facts

Who are Hinge Bio's competitors?

Companies similar to Hinge Bio include HI-Bio, Dren Bio, Peak Bio and BioLoomics.

When was Hinge Bio founded?

Hinge Bio was founded in 2015.

Where is Hinge Bio's headquarters located?

Hinge Bio's headquarters is located in Burlingame, CA, US.

When was Hinge Bio's last funding round?

Hinge Bio's most recent funding round was for $224.5k (USD) in May 2018.

How much has Hinge Bio raised to-date?

As of May 22, 2018, Hinge Bio has raised a total of $224.5k (USD).

How many employees does Hinge Bio have?

Hinge Bio has 34 employees as of Feb 5, 2024.

Hinge Bio - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Antibodies
  • Therapeutics
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified